Furthermore, we validated the differential expression of hsa-miR-499a, AEBP2, and ZNRF1 in HNSCC patients with low, medium, and high tobacco exposure using tumor tissues of HNSCC patients from our research center by qRT-PCR. The gene discussed is AEBP2; the disease is head and neck squamous cell carcinoma.